Clinical Trial Update: BIG 02/98 Docetaxel - Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating docetaxel for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED